Waters Corporation

WAT.US
Healthcare · Diagnostics & Research
383.90
+12.70 (+3.42%)
USD · NYSE

Company Information

Company Name
Waters Corporation
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
ISIN: US9418481035
CIK: 0001000697
CUSIP: 941848103
Currency: USD
Full Time Employees: 16,000
Phone: 508 478 2000
Fiscal Year End: December
IPO Date: Nov 16, 1995
Description:

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Address:

34 Maple Street, Milford, MA, United States, 01757

People

Directors & Officers

Name Title Year Born
Dr. Udit Batra Ph.D. President, CEO & Director 1971
Mr. Amol Chaubal Senior VP & CFO 1977
Ms. Jianqing Y. Bennett Senior Vice President of Waters Advanced Diagnostics 1970
Mr. Robert L. Carpio III Senior Vice President of Waters Analytical Sciences 1983
Mr. Christos Ross Senior Vice President of Global Operations NA
Mr. Brook M. Colangelo Senior VP & Chief Information Officer 1978
Mr. Caspar Tudor Head of Investor Relations NA
Ms. Keeley A. Aleman J.D. Senior VP, General Counsel & Head of Global Human Resources 1977
Ms. Kristen Garvey Senior Vice President of Global Communications NA
Dr. Daniel Rush Ph.D. Senior Vice President of Global Research & Strategy NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 18, 2026 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $295.30 N/A
Mar 16, 2026 Wei Jiang N/A Purchase 500.00 $289.46 $144.73K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 8.54M Mar 31, 2026 8.70% $0.04 57.27%
Vanguard Group Inc 7.47M Dec 31, 2025 7.61% $0.04 -2.44%
Vanguard Capital Management, LLC 6.38M Mar 31, 2026 6.50% $0.05 0.00%
Vanguard Portfolio Management, LLC 4.75M Mar 31, 2026 4.84% $0.07 0.00%
T. Rowe Price Investment Management,Inc. 4.66M Mar 31, 2026 4.75% $0.96 1,728.26%
Massachusetts Financial Services Company 4.63M Mar 31, 2026 4.72% $0.69 76.40%
State Street Corp 4.36M Mar 31, 2026 4.44% $0.04 62.57%
Fundsmith LLP 3.21M Mar 31, 2026 3.27% $7.46 -9.72%
Geode Capital Management, LLC 2.65M Mar 31, 2026 2.70% $0.05 66.09%
Amvescap Plc. 2.17M Mar 31, 2026 2.21% $0.06 85.77%
AllianceBernstein L.P. 2.12M Mar 31, 2026 2.16% $0.26 0.39%
JPMorgan Chase & Co 1.97M Mar 31, 2026 2.01% $0.04 117.95%
HHG PLC 1.64M Mar 31, 2026 1.67% $0.23 21.64%
Arnhold & S. Bleichroeder Advisers, LLC 1.58M Mar 31, 2026 1.60% $0.80 0.00%
Mawer Investment Management Ltd 1.40M Mar 31, 2026 1.43% $2.71 2.30%
Viking Global Investors LP 1.26M Mar 31, 2026 1.28% $1.05 0.00%
Morgan Stanley - Brokerage Accounts 1.22M Mar 31, 2026 1.24% $0.02 69.91%
Veritas Asset Management LLP 1.20M Mar 31, 2026 1.22% $6.06 -26.30%
T. Rowe Price Associates, Inc. 1.12M Mar 31, 2026 1.14% $0.04 67.49%
FUNDSMITH INVESTMENT SERVICES LTD. 1.10M Mar 31, 2026 1.12% $7.41 -4.31%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.12M 3.17% ▼ 0.20% Jun 30, 2026
2 Vanguard 500 Index Investor 2.55M 2.60% ▼ 0.64% Jun 30, 2026
3 Vanguard Mid Cap Index Institutional 2.13M 2.17% ▼ 0.03% Jun 30, 2026
4 T. Rowe Price Capital Appreciation 2.10M 2.14% ▼ 24.95% Jun 30, 2026
5 iShares Core S&P 500 ETF 1.35M 1.38% ▲ 0.32% Jun 30, 2026
6 Fidelity 500 Index 1.26M 1.28% ▼ 0.14% May 31, 2026
7 State Street® SPDR® S&P 500® ETF 1.19M 1.21% ▼ 1.29% Jun 30, 2026
8 Janus Inst Mid Cap Growth CF 1.17M 1.19% ▲ 26.20% Mar 31, 2026
9 Janus Henderson Enterprise D 1.17M 1.19% ▲ 0.00% Apr 30, 2026
10 AllianceBernstein US L/C Growth Eqty MF 1.01M 1.03% ▲ 9.03% May 29, 2026

Financial Highlights

Market Cap: $36.45B
EBITDA: $1.14B
P/E Ratio: $47.17
PEG Ratio: $1.68
Book Value: $155.78
Earnings/Share: $7.87
Profit Margin: 11.93%
Operating Margin: 2.84%
ROA (TTM): 3.31%
ROE (TTM): 5.21%
Revenue (TTM): $3.77B
Revenue/Share (TTM): $57.84
Earnings Growth (YOY): -3.10%
Revenue Growth (YOY): 91.40%

Valuation Metrics

Enterprise Value: $41.90B
Trailing P/E: 47.17
Forward P/E: 26.18

Shares Statistics

Shares Outstanding: 98.19M
Shares Float: 98.00M
% Insiders: 10.30%
% Institutions: 9,999.90%
Short % Float: 3.73%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$3.17B
Cost of Goods Sold
adjust
$-1.34B
Gross Profit
subtotal
$1.83B
SG&A
adjust
$-717.82M
R&D
adjust
$-195.18M
Other Operating Expense
adjust
$-22.45M
Operating Income
subtotal
$893.22M
Other / Non-Operating Items
adjust
$-250.59M
Net Income
subtotal
$642.63M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about WAT.US!